T
Tribun Health
Digital pathology software and diagnostic imaging solutions
About Tribun Health
Tribun Health, founded in 2016 by Jean-François Pomerol, is a company that specializes in the digital transformation of cancer diagnosis. The company provides software solutions for diagnostic laboratories and pharmaceutical/biotech companies, enabling them to manage, analyze, and share cellular images.
Read full description
The company's core business revolves around its digital pathology platform. This platform incorporates artificial intelligence, specifically deep and machine learning algorithms, to assist physicians and researchers in diagnostic decision-making and scientific evaluation. The goal is to enhance the accuracy and efficiency of cancer diagnosis for the benefit of patients.
Tribun Health also offers web-based tools that support telepathology, remote teaching, and multi-center clinical validation activities. This facilitates collaboration among professionals in the field. The company provides customized support to ensure its solutions meet the specific needs of its clients.
At a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Châtillon, France
- Employees
- 54
- Open positions
- None listed
- Dealroom signal
- 66.1/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Medical Devices, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Research and Development, Health Information, Microbiology
- Technology
- Artificial Intelligence, Deep Tech, IoT InternetOfThings
- Business model
- Manufacturing, SaaS
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Tribun Health.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | Apr 2024 | $618K | — | Undisclosed | ↗ |
| SERIES B✓Equity / VC | Sep 2023 | $17M | $66M | Owkin · Vivalto Family · Bpifrance | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Tribun Health is 360 monthly website visits, down 72.3% over the last three months. Tribun Health's team declined 12.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
LBO France
Bpifrance
Owkin- VFVivalto Family
Other known investors1 additional known investor
EIT Health
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tribun Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tribun Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.